Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study
1 other identifier
observational
200
1 country
1
Brief Summary
The traditional concept believes that the etiology of neonatal respiratory distress syndrome (RDS) is immature development of lung,especially the surfactant synthesis system,and RDS is still one of the major causes of mortality and morbidity in newborns, especially premature infants.In recent years, using pulmonary surfactant replacement therapy (PS treatment) in the treatment of respiratory distress syndrome (RDS) is a major breakthrough in neonatal medicine.Combined with clinical practice and experience,and through Meta analysis of related randomized controlled trials (RCTs),it confirms that natural surfactant treatment can reduce mortality,the incidence of pulmonary air leaks (pneumothorax and interstitial lung emphysema),and the incidence of bronchopulmonary dysplasia (BPD) or 28-day-old mortality.For RDS in preterm infants whose gestation is \<35 weeks ,surfactant replacement therapy is also more effective than in nearly term and full term infants.Therefore, in the analysis of cases of different gestational age groups,the investigators should focus on the study of premature infants cases.Due to less relevant research for using PS treatment to cure newborn RDS in high altitude area,this retrospective study conducts statistics and analysis of recently three-year cases in some hospital of high altitude area,to explore the treatment effect of the high altitude region and the impact of altitude on the treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2018
CompletedFirst Posted
Study publicly available on registry
March 27, 2018
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFebruary 17, 2021
February 1, 2021
2.8 years
March 18, 2018
February 14, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
bronchopulmonary dysplasia(BPD)
the incidence of BPD in infants with neonatal neonatal RDS
before discharge or 36 weeks' gestational age
death
the incidence of BPD in infants with neonatal RDS
before discharge or 36 weeks' gestational age
Secondary Outcomes (2)
intraventriclular hemorrhage(IVH)
before discharge or 36 weeks' gestational age
necrotizing enterocolitis(NEC)
before discharge or 36 weeks' gestational age
Interventions
surfactant is given when neonatal respiratory distress syndrome is diagnosed
Eligibility Criteria
the preterm infants less than 37 weeks and diagnosed with NRDS were included in the study.
You may qualify if:
- the preterm infants less than 37 weeks were included in the study;diagnosed with NRDS
You may not qualify if:
- parents' rejecting to join;major congenital abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universitylead
- the first people hospital of Tibet autonomous regioncollaborator
- the second people hospital of Lasacollaborator
- the first people hospital of Shigatsecollaborator
- the first people hospital of Lasacollaborator
- the people hospital of Linzhicollaborator
- the people hospital of Laqucollaborator
Study Sites (1)
Department of Pediatrics, Daping Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, 400042, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 18, 2018
First Posted
March 27, 2018
Study Start
March 1, 2020
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
February 17, 2021
Record last verified: 2021-02